Journal article
Update on intra-arterial chemotherapy for retinoblastoma
TheScientificWorld, Vol.2014, pp.869604-6
2014
DOI: 10.1155/2014/869604
PMCID: PMC4227378
PMID: 25405236
Abstract
The tools for managing retinoblastoma have been increasing in the past decade. While globe-salvage still relies heavily on intravenous chemotherapy, tumors in advanced stage that failed chemotherapy are now referred for intra-arterial chemotherapy (IAC) to avoid enucleation. However, IAC still has many obstacles to overcome. We present an update on the indications, complications, limitations, success, and technical aspects of IAC. Given its safety and high efficacy, it is expected that IAC will replace conventional strategies and will become a first-line option even for tumors that are amenable for other strategies.
Details
- Title: Subtitle
- Update on intra-arterial chemotherapy for retinoblastoma
- Creators
- Mario Zanaty - Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA 19107, USAGuilherme Barros - Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA 19107, USANohra Chalouhi - Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA 19107, USARobert M Starke - Department of Neurosurgery, University of Virginia, Charlottesville, VA 22908, USAPhilip Manasseh - Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA 19107, USAStavropoula I Tjoumakaris - Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA 19107, USACarol L Shields - Department of Ophthalmology, Thomas Jefferson University Hospital, Philadelphia, PA 19017, USADavid Hasan - Department of Neurosurgery, University of Iowa School of Medicine, Iowa City, IA 52242, USAKetan Bulsara - Department of Neurosurgery, Yale University School of Medicine, New Haven, CT 06510, USARobert H Rosenwasser - Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA 19107, USAPascal Jabbour - Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA 19107, USA ; Department of Neurological Surgery, Division of Neurovascular Surgery and Endovascular Neurosurgery, Thomas Jefferson University Hospital, 909 Walnut Street, 2nd Floor, Philadelphia, PA 19107, USA
- Resource Type
- Journal article
- Publication Details
- TheScientificWorld, Vol.2014, pp.869604-6
- DOI
- 10.1155/2014/869604
- PMID
- 25405236
- PMCID
- PMC4227378
- NLM abbreviation
- ScientificWorldJournal
- ISSN
- 2356-6140
- eISSN
- 1537-744X
- Publisher
- United States
- Language
- English
- Date published
- 2014
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Iowa Neuroscience Institute; Neurosurgery; Otolaryngology
- Record Identifier
- 9984040257402771
Metrics
37 Record Views